Vats R. United States Food and Drug Administration’s Accelerated Approval Pathway: Progressive Journey and Opportunities for a Balancing Act for Oncology Drugs. RPS [Internet]. 2025 Jan. 17 [cited 2025 Oct. 9];. Available from: https://repository.e-ssbm.com/index.php/rps/article/view/673